| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/24/2000 | EP1001933A1 Caspases and apoptosis |
| 05/24/2000 | EP1001932A1 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor |
| 05/24/2000 | EP1001930A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 05/24/2000 | EP1001927A2 Novel polyamine analogues as therapeutic and diagnostic agents |
| 05/24/2000 | EP1001924A1 The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives |
| 05/24/2000 | EP1001813A1 Pharmaceutical formulations containing voriconazole |
| 05/24/2000 | EP1001812A1 Composition for the transdermal administration of steroid drugs |
| 05/24/2000 | EP1001802A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor |
| 05/24/2000 | EP1001801A1 Product comprising at least a double stranded rna combined with at least an antiviral agent |
| 05/24/2000 | EP1001797A1 Soya extract, process for its preparation and pharmaceutical composition |
| 05/24/2000 | EP1001796A1 Antacid and papain combination |
| 05/24/2000 | EP1001793A1 Chromium/biotin treatment of type ii diabetes |
| 05/24/2000 | EP1001792A1 Use of physiologically acceptable vanadium compounds, salts and complexes |
| 05/24/2000 | EP1001790A1 Compositions for lubricating and separating tissues and biological membranes |
| 05/24/2000 | EP1001788A1 Boron carbohydrate complexes and uses thereof |
| 05/24/2000 | EP1001787A1 Liver protection or treatment agents comprising asiatic acid derivatives as the active component |
| 05/24/2000 | EP1001786A1 Method of treating rhinoviral infections |
| 05/24/2000 | EP1001785A1 Use of colchinol derivatives as vascular damaging agents |
| 05/24/2000 | EP1001784A1 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor |
| 05/24/2000 | EP1001783A1 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide |
| 05/24/2000 | EP1001782A1 5,6-HETEROARYL-DIPYRIDO 2,3-$i(b):3',2'-$i(f)]AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION |
| 05/24/2000 | EP1001781A2 Use of taurolidine or taurultam for the manufacture of a medicament for the prevention of metastases |
| 05/24/2000 | EP1001780A1 Use of nk-1 receptor antagonists for treating mania |
| 05/24/2000 | EP1001779A1 Use of nk-1 receptor antagonists for treating aggressive behaviour disorders |
| 05/24/2000 | EP1001778A1 Use of a rifamycin derivative for treating mastitis in a domestic animal |
| 05/24/2000 | EP1001777A1 Fibrinogen receptor antagonists |
| 05/24/2000 | EP1001776A1 Aroylpiperazines for modulating sexual activity |
| 05/24/2000 | EP1001775A1 Medicine containing yohimbine and arginine for treating erectile dysfunction |
| 05/24/2000 | EP1001774A1 Use of phospholamban inhibitors to increasing coronary flow |
| 05/24/2000 | EP1001773A1 Oral solid pharmaceutical compositions containing nicorandil for a modulated release and the process for their preparation |
| 05/24/2000 | EP1001772A1 Improved delivery of multiple doses of medications |
| 05/24/2000 | EP1001771A1 A medicament against infertility and for increasing fertility |
| 05/24/2000 | EP1001770A1 Tazarotene and uvb phototherapy treatment for psoriasis |
| 05/24/2000 | EP1001769A4 Soluble prodrugs of paclitaxel |
| 05/24/2000 | EP1001769A1 Soluble prodrugs of paclitaxel |
| 05/24/2000 | EP1001768A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor |
| 05/24/2000 | EP1001767A1 Anti-viral compounds |
| 05/24/2000 | EP1001766A1 Compounds and methods |
| 05/24/2000 | EP1001764A1 Heterocyclic amide compounds as cell adhesion inhibitors |
| 05/24/2000 | EP1001763A1 Aqueous compositions comprising ranitidine and lcmt sucrose |
| 05/24/2000 | EP1001762A1 Method of using neurotrophic carbamates and ureas |
| 05/24/2000 | EP1001761A1 Use of cholinesterase inhibitors for treating attention deficit disorders |
| 05/24/2000 | EP1001760A1 Composition for controlling mood disorders in healthy individuals |
| 05/24/2000 | EP1001759A2 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 05/24/2000 | EP1001758A1 Use of a drug capable of modulating the regulation of upc-2 and method for screening for potential drugs against obesity |
| 05/24/2000 | EP1001757A1 Fast-acting analgesic |
| 05/24/2000 | EP1001756A1 Synergistically acting compositions for selectively combating tumor tissue |
| 05/24/2000 | EP1001755A2 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 05/24/2000 | EP1001754A1 Use of a pharmaceutical composition in the treatment of traumatic arthritis in horses |
| 05/24/2000 | EP1001753A1 Low dosed 15-desoxyspergualine preparations |
| 05/24/2000 | EP1001752A1 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
| 05/24/2000 | EP1001750A1 Stable particulate complexes with neutral or negative globale charge of lamellar structure |
| 05/24/2000 | EP1001749A1 Proliposome powders for inhalation stabilised by tocopherol |
| 05/24/2000 | EP1001747A1 Compositions for nasal administration |
| 05/24/2000 | EP1001746A1 Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
| 05/24/2000 | EP1001739A1 Use of a 2-amino-alkane polyol as agent for treating skin ageing signs |
| 05/24/2000 | EP1001737A1 Intra-oral antioxidant preparations |
| 05/24/2000 | EP1001686A1 Dehydration plant |
| 05/24/2000 | EP1001685A1 Nutritional composition containing methionine |
| 05/24/2000 | EP1001677A1 A novel method for treating epidermal or dermal conditions |
| 05/24/2000 | EP0931083A4 Process for producing ecteinascidin compounds |
| 05/24/2000 | EP0817767B1 Bicyclic amine derivatives and their use as anti-psychotic agents |
| 05/24/2000 | EP0815095B1 10-deacetylbaccatine iii and 10-deacetyl 14 beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and pharmaceutical compositions containing them |
| 05/24/2000 | EP0799238B1 14alpha,17alpha-c2-bridged 19-nor-progesterone derivatives |
| 05/24/2000 | EP0794788A4 Hepatic-directed compounds and reagents for preparation thereof |
| 05/24/2000 | EP0787135B1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer |
| 05/24/2000 | EP0769017B1 Therapeutic compounds |
| 05/24/2000 | EP0724452B1 Pharmaceutical composition containing cyclosporine a, a vitamine e derivative and an emulsifier |
| 05/24/2000 | EP0722325B1 Composition for the treatment or prevention of herpes |
| 05/24/2000 | EP0720620B1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 05/24/2000 | EP0717990B1 Composition for remedying drug dependence |
| 05/24/2000 | EP0679156B1 Process for the preparation of 10-desacetoxybaccatin III and 10-desacetoxytaxol and derivatives thereof |
| 05/24/2000 | EP0671879B1 Prevention of injury and degeneration of photoreceptors by neurotrophic factors |
| 05/24/2000 | EP0637315B1 Adenosine derivatives having a2 agonist activity |
| 05/24/2000 | EP0626969B1 CoA-IT AND PAF INHIBITORS |
| 05/24/2000 | EP0619735B1 Lyophilized composition containing s(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione) |
| 05/24/2000 | CN1254376A 端粒酶逆转录酶 Telomerase reverse transcriptase |
| 05/24/2000 | CN1254344A Estrogenic 10-Noradnrost-17-one derivatives with aromatic B-ring |
| 05/24/2000 | CN1254343A Pregnane 3,20 diol mono- and di-sulphates |
| 05/24/2000 | CN1254342A Pharmaceutically acceptable salts of 5 alpha-pregnan-3-beta, 16 alpha-diol-20-one 3-sulfate useful as progestins and CNS disorders |
| 05/24/2000 | CN1254341A Pharmaceutically accpetable salts of 3-hydroxy-estr-5-(10)-en-17-one 3-sulphate active as estrogens |
| 05/24/2000 | CN1254339A Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 05/24/2000 | CN1254337A N-hydroxy 4-sulfonyl butyramide compounds |
| 05/24/2000 | CN1254335A Nicotinamide derivatives |
| 05/24/2000 | CN1254333A Immunotherapeutic imides/amides |
| 05/24/2000 | CN1254294A Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof |
| 05/24/2000 | CN1254293A Targeted therapeutic delivery of vitamin D compounds |
| 05/24/2000 | CN1254288A Condensation polymer composition for preventing pregnancy |
| 05/24/2000 | CN1254286A Composition for prevention of hepatic steatosis |
| 05/24/2000 | CN1254285A Use of zinc hyaluronate against peptic ulcer |
| 05/24/2000 | CN1254284A Activated protein C formulations |
| 05/24/2000 | CN1254283A Pregnan-3-ol-20-ones |
| 05/24/2000 | CN1254282A Benzimidazole-2-carbamates for treatment of viral infections and cancer |
| 05/24/2000 | CN1254281A HIV and cancer treatment |
| 05/24/2000 | CN1254279A Methods and compositions for treatment of ovarian cancer |
| 05/24/2000 | CN1254278A Pharmaceutical injection solution containing taxol |
| 05/24/2000 | CN1254255A Methods for reducing fibrinogen |
| 05/24/2000 | CN1253948A Substituted tricyclic compound |
| 05/24/2000 | CN1253833A Cell adhesion molecule expression inhibitor |
| 05/24/2000 | CN1253812A Shaotangning medicine for curing burn and scald and its preparation method |